Browse Category

NASDAQ:MDLN News 9 December 2025 - 18 December 2025

Medline Stock (MDLN) After the Bell: IPO Closes, Shares Ease to $39.49 — What to Know Before Market Open Dec. 19, 2025

Medline Stock (MDLN) After the Bell: IPO Closes, Shares Ease to $39.49 — What to Know Before Market Open Dec. 19, 2025

Medline Inc. (Nasdaq: MDLN) is getting a quick reality check after one of the biggest U.S. IPO debuts in years. After the closing bell on Thursday, December 18, 2025, Medline stock finished the regular session at $39.98 (down 2.49% on the day) and traded around $39.49 in after-hours action, after moving between $38.00 and $41.74 during the day. Investing.com The timing matters: today wasn’t just “day two volatility.” Medline also officially closed its upsized IPO and confirmed that underwriters fully exercised their option for additional shares—an update that helps investors understand near-term share supply, stabilization mechanics, and how quickly the
18 December 2025
Medline Inc. Class A Common Stock MDLN Stock News and Forecast: Shares Surge After 2025’s Biggest IPO as Debt and Tariff Risks Take Center Stage

Medline Inc. Class A Common Stock MDLN Stock News and Forecast: Shares Surge After 2025’s Biggest IPO as Debt and Tariff Risks Take Center Stage

Medline Inc. Class A Common Stock—trading on the Nasdaq Global Select Market under the ticker MDLN—is having the kind of debut that makes IPO bankers briefly believe in destiny again. On Wednesday, December 17, 2025, Medline shares opened at $35 after pricing its IPO at $29, then finished the session at $41, a gain of about 41% on day one. Reuters+2Investopedia+2 On Thursday, December 18, 2025, early indications showed the stock pulling back in pre-market trading—around $39.73 as of 4:01 a.m. ET, down roughly 3% from the prior close—an unsurprising “welcome to price discovery” move after a first-day pop. StockAnalysis
18 December 2025
Medline IPO: MDLN Debuts on Nasdaq After $6.26 Billion Raise in 2025’s Biggest Global Listing

Medline IPO: MDLN Debuts on Nasdaq After $6.26 Billion Raise in 2025’s Biggest Global Listing

Medline is officially back in the public markets. On Wednesday, December 17, 2025, the Northfield, Illinois-based medical supply powerhouse begins trading on the Nasdaq Global Select Market under the ticker MDLN, following an upsized initial public offering that raised about $6.26 billion—the largest global IPO of 2025. Reuters+2Medline Newsroom+2 For Wall Street, the scale of the deal matters. For hospitals and health systems, the company’s name is already familiar: Medline sits deep inside the day-to-day plumbing of healthcare, supplying everything from surgical kits and gloves to protective apparel and logistics services. The IPO is also a major moment for the
17 December 2025
Medline IPO 2025: Inside the $5.37 Billion Nasdaq Listing and One of Private Equity’s Biggest Exits

Medline IPO 2025: Inside the $5.37 Billion Nasdaq Listing and One of Private Equity’s Biggest Exits

NEW YORK / NORTHFIELD, Ill. — December 9, 2025 — Medical‑supply giant Medline Inc. has set the terms for a U.S. initial public offering that could raise up to $5.37 billion and value the company at as much as $55.3 billion, positioning it as the largest U.S. IPO of 2025 and one of the biggest private‑equity‑backed listings on record.Reuters+1 The Illinois‑based manufacturer and distributor of medical‑surgical supplies plans to sell 179 million shares on the Nasdaq under the ticker MDLN at a price range of $26 to $30 per share, with Goldman Sachs, Morgan Stanley, BofA Securities and J.P. Morgan
9 December 2025

Stock Market Today

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
Go toTop